Search Results

You are looking at 61 - 70 of 93 items for :

  • Medical and Health Sciences x
  • Refine by Access: Content accessible to me x
Clear All

, psilocybin, MDMA, and ketamine . The Journal of Neuroscience , 41 ( 5 ), 891 – 900 . https://doi.org/10.1523/jneurosci.1659-20.2020 . 10.1523/JNEUROSCI.1659

Open access

-being or mental health. Accordingly, the following types of research were excluded: reviews or other non-empirical work, purely qualitative studies, studies on other psychoactive substances such as ketamine, cannabis or MDMA, studies on microdosing, studies

Open access

to rate how often their use of each of 12 drug categories (alcohol, tobacco, cannabis, MDMA, amphetamines, cocaine, opiates, classic psychedelics, inhalants, sedatives/hypnotics, dissociatives, atypical psychedelics) is motivated by entheogenic

Open access

. , & Meester , M. ( 2012 ). Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner . Journal of Psychoactive Drugs

Open access

Psychedelics and critical theory

A response to Hauskeller's individualization and alienation in psychedelic psychotherapy

Journal of Psychedelic Studies
Authors:
Julien Tempone-Wiltshire
and
Tra-ill Dowie

not dismiss concerns raised around the cultural appropriation of Indigenous knowledges, it is important to recognise that the most medically-applied psychedelics to date are MDMA, LSD, psylocibin and ketamine—three out of four of which are in no way

Open access

experience induced by non-classic psychedelics such as MDMA or ketamine ( Carhart-Harris et al., 2014 ; Glennon et al., 1984 ). It was hypothesized that ego-dissolution and connectedness would positively correlate with mental health and wellbeing

Open access

%) Ayahuasca 4 (2%) 5-HT-2A research chemicals 3 (1%) Drug History LSD 174 (80%) Psilocybin 154 (71%) MDMA 38 (17%) DMT 29 (13%) Mescaline 28 (13%) Ayahuasca 5 (2%) 5-HT-2A research chemicals 12 (6%) Note . N represents the sum total number of participants who

Open access

, Reed, and Aggarwal ( 2019 ) describe culturally informed research design and treatment issues, with respect to a 3,4-methylenedioxy-methamphetamine (MDMA)-assisted psychotherapy study for post-traumatic stress disorder (PTSD) at a university medical

Open access

suggested to be beneficial in the treatment of substance-use disorders ( dos Santos et al., 2016 ; Krebs & Johansen, 2012 ). Similarly, 3,4,-methylenedioxymethamphetamine (MDMA) has been shown to be efficacious as an adjunct to psychotherapy in the

Open access

: psilocybin in the treatment of depressive disorders and 3,4-methylenedioxymethamphetamine (MDMA) in the treatment of post-traumatic stress disorder (PTSD; For the purposes of this commentary, MDMA is considered a psychedelic – not only as a cultural or a

Open access